No article text was recorded for this version.
waning immunity modeling
Version 2 of 283 papers117 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Resistance is Futile: Gradually Declining Immunity Retains the Exponential Duration of Immunity-Free Diffusion
- Blog: Impact of waning immunity against SARS-CoV-2 severity exacerbated by vaccine hesitancy
- Blog: RTS,S/AS01 Malaria Vaccine Efficacy is Not Modified by Seasonal Precipitation: Results from a Phase 3 Randomized Controlled Trial in Malawi
- Blog: Influenza Vaccine Effectiveness against Influenza A-Associated Outpatient and Emergency-Department-Attended Influenza-like Illness during the Delayed 2022–2023 Season in Beijing, China
- Blog: Evaluating the impact of extended dosing intervals on mRNA COVID-19 vaccine effectiveness in adolescents
- Blog: The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120
- Blog: Analyzing Social Distancing and Seasonality of COVID-19 with Mean Field Evolutionary Dynamics
- Blog: Predicting COVID-19 pandemic waves including vaccination data with deep learning
- Blog: Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection
- Blog: Immune Persistence against SARS-CoV-2 after Primary and Booster Immunization in Humans: A Large-Scale Prospective Cohort Study
- Blog: Real-World COVID-19 Vaccine Protection Rates against Infection in the Delta and Omicron Eras
- Blog: Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine
- Blog: Barrier gesture relaxation during vaccination campaign in France: modelling impact of waning immunity
- Blog: Toward the Impact of Non-pharmaceutical Interventions and Vaccination on the COVID-19 Pandemic With Time-Dependent SEIR Model
- Blog: Using survey data to estimate the impact of the omicron variant on vaccine efficacy against COVID-19 infection
- Blog: Assessing factors associated with one-year antibody waning in participants with repeated influenza vaccinations: A six-year cohort study
- Blog: Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina
- Blog: Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost
- Blog: Prophylactic and reactive vaccination strategies for healthcare workers against MERS-CoV
- Blog: Epidemiological Assessment and Optimization of School-Based Influenza Vaccination — Shenzhen City, Guangdong Province, China, 2023–2024
- Blog: Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging Variants
- Blog: Optimal protection and vaccination against epidemics with reinfection risk
- Blog: Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: a retrospective cohort study
- Blog: Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines
- Blog: Projected resurgence of COVID-19 in the United States in July—December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination
- Blog: Delays, Masks, the Elderly, and Schools: First Covid-19 Wave in the Czech Republic
- Blog: Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
- Blog: Equitable access to COVID-19 vaccines makes a life-saving difference to all countries
- Blog: Pandemic Control, Game Theory and Machine Learning
- Blog: Estimation and Hypothesis Testing of Strain-Specific Vaccine Efficacy with Missing Strain Types, with Applications to a COVID-19 Vaccine Trial
- Blog: Pharmacokinetics and predicted neutralization coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials
- Blog: When and How to Lift the Lockdown? Global COVID-19 Scenario Analysis and Policy Assessment using Compartmental Gaussian Processes
- Blog: Two-population SIR model and strategies to reduce mortality in pandemics
- Blog: Impact of vaccination on SARS-CoV-2 transmission in the UK: a modelling study
- Blog: Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
- Blog: Transient Dynamics of Epidemic Spreading and its Mitigation on Large Networks
- Blog: Forcing Versus Feedback: Epidemic Malaria and Monsoon Rains in Northwest India
- Blog: Hepatitis B vaccination on hemodialysis patients - Cellular immunity and the course of antibody response.
- Blog: Stages of COVID-19 pandemic and paths to herd immunity by vaccination: dynamical model comparing Austria, Luxembourg and Sweden
- Blog: Optimizing Vaccine Allocation Strategies in Pandemic Outbreaks: An Optimal Control Approach
- Blog: How enlightened self-interest guided global vaccine sharing benefits all: a modelling study
- Blog: The minimal COVID-19 vaccination coverage and efficacy to compensate for a potential increase of transmission contacts, and increased transmission probability of the emerging strains
- Blog: Quantifying the potential dominance of immune-evading SARS-CoV-2 variants in the United States
- Blog: Evaluating the impact of extended dosing intervals on mRNA COVID-19 vaccine effectiveness in adolescents
- Blog: Estimating the COVID-19 epidemic trajectory and hospital capacity requirements in South West England: a mathematical modelling framework
- Blog: Bayesian workflow for time-varying transmission in stratified compartmental infectious disease transmission models
- Blog: SIDIR: Extending SIR with Detected and Isolated Populations for Pandemic Modeling
- Blog: Antibody escape, the risk of serotype formation, and rapid immune waning: modeling the implications of SARS-CoV-2 immune evasion
- Blog: Age-Stratified COVID-19 Spread Analysis and Vaccination: A Multitype Random Network Approach
- Blog: Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB Reinfection
- Blog: Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
- Blog: A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil
- Blog: Strategies to Mitigate COVID-19 Resurgence Assuming Immunity Waning: A Study for Karnataka, India
- Blog: Global Dynamics of an Age-Structured Tuberculosis Model with Vaccine Failure and Nonlinear Infection Force
- Blog: Immune responses to inactivated COVID-19 vaccine were decreased in Chinese patients with chronic respiratory diseases
- Blog: Are all underimmunized measles clusters equally critical?
- Blog: D2EA: Depict the Epidemic Picture of COVID-19
- Blog: Estimating the impact of vaccination on reducing COVID-19 burden in the United States: December 2020 to March 2022
- Blog: Epidemiology of Influenza Virus Reinfection: A Retrospective Analysis of a Nine-year Influenza Surveillance Data
- Blog: Age-Stratified Infection Probabilities Combined With a Quarantine-Modified Model for COVID-19 Needs Assessments: Model Development Study
Showing 60 of 83 papers.
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_waning_immunity_modeling_6341f452,
title = {waning immunity modeling},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/waning-immunity-modeling/rdr_6341f452cac747a3aabe614eaa2ad7c3},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 2, frozen text):
@misc{lacuna_waning_immunity_modeling_6341f452_v2,
title = {waning immunity modeling},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/waning-immunity-modeling/rdr_6341f452cac747a3aabe614eaa2ad7c3/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-20},
}